120.66
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt A?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$120.45
Offen:
$121
24-Stunden-Volumen:
1.47M
Relative Volume:
0.67
Marktkapitalisierung:
$34.24B
Einnahmen:
$6.63B
Nettoeinkommen (Verlust:
$1.17B
KGV:
29.79
EPS:
4.05
Netto-Cashflow:
$1.19B
1W Leistung:
+1.72%
1M Leistung:
+8.65%
6M Leistung:
-9.57%
1J Leistung:
-4.07%
Agilent Technologies Inc Stock (A) Company Profile
Firmenname
Agilent Technologies Inc
Sektor
Branche
Telefon
(408) 345-8886
Adresse
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Vergleichen Sie A mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
A
Agilent Technologies Inc
|
120.66 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
TMO
Thermo Fisher Scientific Inc
|
427.76 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
202.50 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
542.71 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
IQV
Iqvia Holdings Inc
|
164.65 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2024-06-03 | Fortgesetzt | Jefferies | Hold |
2024-04-05 | Hochstufung | Stifel | Hold → Buy |
2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
2023-12-12 | Herabstufung | BofA Securities | Buy → Neutral |
2023-11-17 | Herabstufung | UBS | Buy → Neutral |
2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
2023-05-24 | Bestätigt | Barclays | Equal Weight |
2023-05-24 | Bestätigt | BofA Securities | Buy |
2023-05-24 | Bestätigt | Citigroup | Neutral |
2023-05-24 | Bestätigt | Credit Suisse | Outperform |
2023-05-24 | Bestätigt | Evercore ISI | Outperform |
2023-05-24 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2023-05-24 | Bestätigt | Robert W. Baird | Outperform |
2023-05-24 | Bestätigt | SVB Securities | Outperform |
2023-05-24 | Bestätigt | Stifel | Hold |
2023-05-24 | Bestätigt | TD Cowen | Outperform |
2023-05-24 | Bestätigt | Wells Fargo | Overweight |
2023-05-11 | Eingeleitet | Barclays | Equal Weight |
2023-01-10 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
2022-07-20 | Eingeleitet | UBS | Buy |
2022-07-08 | Herabstufung | Citigroup | Buy → Neutral |
2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-02-23 | Bestätigt | BofA Securities | Buy |
2022-02-23 | Bestätigt | Citigroup | Buy |
2022-02-23 | Bestätigt | Cowen | Outperform |
2022-02-23 | Bestätigt | Evercore ISI | Outperform |
2022-02-23 | Bestätigt | Stifel | Hold |
2022-02-23 | Bestätigt | Wells Fargo | Overweight |
2021-11-23 | Bestätigt | BofA Securities | Buy |
2021-11-23 | Bestätigt | Cowen | Outperform |
2021-11-23 | Bestätigt | Stifel | Hold |
2021-03-18 | Hochstufung | Citigroup | Neutral → Buy |
2021-02-17 | Hochstufung | BofA Securities | Neutral → Buy |
2020-12-02 | Eingeleitet | Goldman | Buy |
2020-11-25 | Hochstufung | UBS | Neutral → Buy |
2020-11-17 | Hochstufung | Cleveland Research | Neutral → Buy |
2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2020-09-30 | Eingeleitet | Atlantic Equities | Neutral |
2020-08-19 | Bestätigt | BofA Securities | Neutral |
2020-08-19 | Bestätigt | Citigroup | Neutral |
2020-08-19 | Bestätigt | Jefferies | Buy |
2020-08-19 | Bestätigt | Robert W. Baird | Outperform |
2020-08-19 | Bestätigt | SVB Leerink | Outperform |
2020-08-19 | Bestätigt | Stifel | Hold |
2020-08-19 | Bestätigt | Wells Fargo | Overweight |
2020-02-24 | Herabstufung | Needham | Buy → Hold |
2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
2020-01-07 | Eingeleitet | Citigroup | Neutral |
2019-11-26 | Bestätigt | Needham | Buy |
2019-11-15 | Eingeleitet | Stifel | Hold |
2019-10-18 | Herabstufung | UBS | Buy → Neutral |
2019-07-16 | Herabstufung | BofA/Merrill | Buy → Neutral |
2019-07-15 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Agilent Technologies Inc Aktie (A) Neueste Nachrichten
Vaughan Nelson Investment Management L.P. Cuts Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Mn Services Vermogensbeheer B.V. Sells 8,300 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Assenagon Asset Management S.A. Boosts Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Zacks Research Has Pessimistic Outlook of A Q3 Earnings - MarketBeat
Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board - GlobeNewswire Inc.
Agilent Technologies, Inc. (NYSE:A) Shares Sold by QRG Capital Management Inc. - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Position Cut by Fifth Third Bancorp - MarketBeat
How Did Agilent Technologies (NYSE:A) Perform On The NYSE Index in Q1? - Kalkine Media
Louisbourg Investments Inc. Increases Stake in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
PKO Investment Management Joint Stock Co Has $994,000 Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
JLB & Associates Inc. Raises Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
New England Research & Management Inc. Makes New $1.66 Million Investment in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Q1 Earnings Highlights: Agilent (NYSE:A) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
SG Americas Securities LLC Sells 44,510 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies (NYSE:A) Cut to Hold at Wall Street Zen - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Shares Bought by Quintet Private Bank Europe S.A. - MarketBeat
Is Agilent Technologies Stock Underperforming the Dow? - MSN
Fiduciary Financial Group LLC Makes New Investment in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Central Valley Advisors LLC Acquires Shares of 15,845 Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Protein Chips Industry Analysis (2025-2030) Featuring - GlobeNewswire
Protein Chips Industry Analysis (2025-2030) Featuring Strategic Profiles of 42 Market Players Including Abcam, Agilent and Roche Diagnostics - Yahoo Finance
Tounjian Advisory Partners LLC Acquires Shares of 9,982 Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Fenimore Asset Management Inc Sells 3,416 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies (NYSE:A) Unveils Cutting-Edge Lab Innovations At HPLC 2025 Conference - simplywall.st
Agilent to Showcase New Products and Innovations At HPLC 2025 - marketscreener.com
Agilent Technologies’ SWOT analysis: stock upgrade amid uncertain outlook By Investing.com - Investing.com Nigeria
Agilent Technologies’ SWOT analysis: stock upgrade amid uncertain outlook - Investing.com
Here’s Why Agilent (A) Traded Down in Q1 - MSN
Agilent to Showcase New Products and Innovations at HPLC 2025 | A Stock News - GuruFocus
Agilent to Showcase New Products and Innovations at HPLC 2025 - Business Wire
Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid - PR Newswire
NBC Securities Inc. Purchases 2,274 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
Fed. Circ. Backs PTAB Invalidation Of Agilent CRISPR Patents - Law360
Agilent Technologies, Inc. (NYSE:A) Receives $140.15 Consensus Target Price from Brokerages - MarketBeat
Is Agilent Technologies Stock Underperforming The Dow? - Barchart.com
Godsey & Gibb Inc. Raises Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies Inc (A) Stock Price Up 3.58% on Jun 10 - GuruFocus
$101.5 Bn Oncology Diagnostics Global Markets, 2023-2024 & - GlobeNewswire
Finanzdaten der Agilent Technologies Inc-Aktie (A)
Umsatz
Nettogewinn
Free Cashflow
ENV
Agilent Technologies Inc-Aktie (A) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Podolsky Daniel K | Director |
Mar 31 '25 |
Sale |
116.46 |
1,819 |
211,844 |
35,737 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):